Mutation Glu82Lys in lamin A/C gene is associated with cardiomyopathy and conduction defect

Biochemical and Biophysical Research Communications

Volumn 344, Issue 1, 2006, Pages 17-24

  Wang, Hu ^a   Wang, Jizheng ^a   Zheng, Weiyue ^a   Wang, Xiaojian ^a   Wang, Shuxia ^a   Song, Lei ^a   Zou, Yubao ^a   Yao, Yan ^a   Hui, Rutai ^a  

^a FuWai Cardiovascular Hospital   (China)

Author keywords

Dilated cardiomyopathy; Lamin A C gene; Mutation

Indexed keywords

EMERIN; LAMININ;

ADULT; AMINO ACID SUBSTITUTION; ARTICLE; CELL NUCLEUS MEMBRANE; CHINESE; CONGESTIVE CARDIOMYOPATHY; CONTROLLED STUDY; EMBRYO; FAMILY; FEMALE; GENE MUTATION; GENETIC DISORDER; GENETIC SCREENING; GENETIC TRANSFECTION; HEART DILATATION; HEART MUSCLE CONDUCTION DISTURBANCE; HETEROCHROMATIN; HUMAN; HUMAN CELL; MALE; MEMBRANE STRUCTURE; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN FAMILY; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; SCHOOL CHILD; TRANSMISSION ELECTRON MICROSCOPY; WILD TYPE;

ADULT; AMINO ACID SEQUENCE; AMINO ACID SUBSTITUTION; ASIAN CONTINENTAL ANCESTRY GROUP; CARDIOMYOPATHY, DILATED; CELL NUCLEUS; CELLS, CULTURED; CHILD; FEMALE; GLUTAMIC ACID; HEART BLOCK; HEART CONDUCTION SYSTEM; HUMANS; LAMIN TYPE A; LYSINE; MALE; MEMBRANE PROTEINS; MOLECULAR SEQUENCE DATA; NUCLEAR ENVELOPE; NUCLEAR PROTEINS; PEDIGREE; POINT MUTATION; THYMOPOIETINS;

EID: 33646486276     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2006.03.149     Document Type: Article

References (34)

1. Richardson P., McKenna W., Bristow M., Maisch B., Mautner B., O'Connell J., Olsen E., Thiene G., Goodwin J., Gyarfas I., Martin I., and Nordet P. Report of the 1995 World Health Organization/International Society and Federation of Cardiology Task Force on the Definition and Classification of cardiomyopathies. Circulation 93 (1996) 841-842
2. Komajda M., Jais J.P., Reeves F., Goldfarb B., Bouhour J.B., Juillieres Y., Lanfranchi J., Peycelon P., Geslin P., and Carrie D. Factors predicting mortality in idiopathic dilated cardiomyopathy. Eur. Heart J. 11 (1990) 824-831
3. Codd M.B., Sugrue D.D., Gersh B.J., and Melton L.J. Epidemiology of idiopathic dilated and hypertrophic cardiomyopathy. A population-based study in Olmsted County, Minnesota, 1975-1984. Circulation 80 (1989) 564-572
4. Kasper E.K., Agema W.R., Hutchins G.M., Deckers J.W., Hare J.M., and Baughman K.L. The causes of dilated cardiomyopathy: a clinicopathologic review of 673 consecutive patients. J. Am. Coll. Cardiol. 23 (1994) 586-590
5. Mestroni L., Miani D., Di Lenarda A., Silvestri F., Bussani R., Filippi G., and Camerini F. Clinical and pathologic study of familial dilated cardiomyopathy. Am. J. Cardiol. 65 (1990) 1449-1453
6. Michels V.V., Moll P.P., Miller F.A., Tajik A.J., Chu J.S., Driscoll D.J., Burnett J.C., Rodeheffer R.J., Chesebro J.H., and Tazelaar H.D. The frequency of familial dilated cardiomyopathy in a series of patients with idiopathic dilated cardiomyopathy. N. Engl. J. Med. 326 (1992) 77-82
7. Worman H.J., and Courvalin J.C. How do mutations in lamins A and C cause disease?. J. Clin. Invest. 113 (2004) 349-351
8. Lin F., and Worman H.J. Structural organization of the human gene encoding nuclear lamin A and nuclear lamin C. J. Biol. Chem. 268 (1993) 16321-16326
9. Hutchison C.J., Alvarez-Reyes M., and Vaughan O.A. Lamins in disease: why do ubiquitously expressed nuclear envelope proteins give rise to tissue-specific disease phenotypes?. J. Cell Sci. 114 (2001) 9-19
10. Stuurman N., Heins S., and Aebi U. Nuclear lamins: their structure, assembly, and interactions. J. Struct. Biol. 122 (1998) 42-66
11. Goldman R.D., Gruenbaum Y., Moir R.D., Shumaker D.K., and Spann T.P. Nuclear lamins: building blocks of nuclear architecture. Genes Dev. 16 (2002) 533-547
12. Wilson K.L. The nuclear envelope, muscular dystrophy and gene expression. Trends Cell Biol. 10 (2000) 125-129
13. Gruenbaum Y., Goldman R.D., Meyuhas R., Mills E., Margalit A., Fridkin A., Dayani Y., Prokocimer M., and Enosh A. The nuclear lamina and its functions in the nucleus. Int. Rev. Cytol. 226 (2003) 1-62
14. Shinbane J.S., Wood M.A., Jensen D.N., Ellenbogen K.A., Fitzpatrick A.P., and Scheinman M.M. Tachycardia-induced cardiomyopathy: a review of animal models and clinical studies. J. Am. Coll. Cardiol. 29 (1997) 709-715
15. Fatkin D., MacRae C., Sasaki T., Wolff M.R., Porcu M., Frenneaux M., Atherton J., Vidaillet Jr. H.J., Spudich S., De Girolami U., Seidman J.G., Seidman C., Muntoni F., Muehle G., Johnson W., and McDonough B. Missense mutations in the rod domain of the lamin A/C gene as causes of dilated cardiomyopathy and conduction-system disease. N. Engl. J. Med. 341 (1999) 1715-1724
16. Hershberger R.E., Hanson E.L., Jakobs P.M., Keegan H., Coates K., Bousman S., and Litt M. A novel lamin A/C mutation in a family with dilated cardiomyopathy, prominent conduction system disease, and need for permanent pacemaker implantation. Am. Heart J. 144 (2002) 1081-1086
17. Becane H.M., Bonne G., Varnous S., Muchir A., Ortega V., Hammouda E.H., Urtizberea J.A., Lavergne T., Fardeau M., Eymard B., Weber S., Schwartz K., and Duboc D. High incidence of sudden death with conduction system and myocardial disease due to lamins A and C gene mutation. Pacing Clin. Electrophysiol. 23 (2000) 1661-1666
18. Arbustini E., Pilotto A., Repetto A., Grasso M., Negri A., Diegoli M., Campana C., Scelsi L., Baldini E., Gavazzi A., and Tavazzi L. Autosomal dominant dilated cardiomyopathy with atrioventricular block: a lamin A/C defect-related disease. J. Am. Coll. Cardiol. 39 (2002) 981-990
19. Genschel J., and Schmidt H.H. Mutations in the LMNA gene encoding lamin A/C. Hum. Mutat. 16 (2000) 451-459
20. Forissier J.F., Bonne G., Bouchier C., Duboscq-Bidot L., Richard P., Wisnewski C., Briault S., Moraine C., Dubourg O., Schwartz K., and Komajda M. Apical left ventricular aneurysm without atrio-ventricular block due to a lamin A/C gene mutation. Eur. J. Heart Fail. 5 (2003) 821-825
21. Hermida-Prieto M., Monserrat L., Castro-Beiras A., Laredo R., Soler R., Peteiro J., Rodriguez E., Bouzas B., Alvarez N., Muniz J., and Crespo-Leiro M. Familial dilated cardiomyopathy and isolated left ventricular noncompaction associated with lamin A/C gene mutations. Am. J. Cardiol. 94 (2004) 50-54
22. Gerace L., Blum A., and Blobel G. Immunocytochemical localization of the major polypeptides of the nuclear pore complex-lamina fraction. Interphase and mitotic distribution. J. Cell Biol. 79 (1978) 546-566
23. Sullivan T., Escalante-Alcalde D., Bhatt H., Anver M., Bhat N., Nagashima K., Stewart C.L., and Burke B. Loss of A-type lamin expression compromises nuclear envelope integrity leading to muscular dystrophy. J. Cell Biol. 147 (1999) 913-920
24. Dalakas M.C., Park K.Y., Semino-Mora C., Lee H.S., Sivakumar K., and Goldfarb L.G. Desmin myopathy, a skeletal myopathy with cardiomyopathy caused by mutations in the desmin gene. N. Engl. J. Med. 342 (2000) 770-780
25. Lammerding J., Schulze P.C., Takahashi T., Kozlov S., Sullivan T., Kamm R.D., Stewart C.L., and Lee R.T. Lamin A/C deficiency causes defective nuclear mechanics and mechanotransduction. J. Clin. Invest. 113 (2004) 370-378
26. Nikolova V., Leimena C., McMahon A.C., Tan J.C., Chandar S., Jogia D., Kesteven S.H., Michalicek J., Otway R., Verheyen F., Rainer S., Stewart C.L., Martin D., Feneley M.P., and Fatkin D. Defects in nuclear structure and function promote dilated cardiomyopathy in lamin A/C-deficient mice. J. Clin. Invest. 113 (2004) 357-369
27. Fidzianska A., Toniolo D., and Hausmanowa-Petrusewicz I. Ultrastructural abnormality of sarcolemmal nuclei in Emery-Dreifuss muscular dystrophy (EDMD). J. Neurol. Sci. 159 (1998) 88-93
28. Goldman R.D., Shumaker D.K., Erdos M.R., Eriksson M., Goldman A.E., Gordon L.B., Gruenbaum Y., Khuon S., Mendez M., Varga R., and Collins F.S. Accumulation of mutant lamin A causes progressive changes in nuclear architecture in Hutchinson-Gilford progeria syndrome. Proc. Natl. Acad. Sci. USA 101 (2004) 8963-8968
29. Spann T.P., Moir R.D., Goldman A.E., Stick R., and Goldman R.D. Disruption of nuclear lamin organization alters the distribution of replication factors and inhibits DNA synthesis. J. Cell Biol. 136 (1997)
30. Clements L., Manilal S., Love D.R., and Morris G.E. Direct interaction between emerin and lamin A. Biochem. Biophys. Res. Commun. 267 (2000) 709-714
31. Ostlund C., Bonne G., Schwartz K., and Worman H.J. Properties of lamin A mutants found in Emery-Dreifuss muscular dystrophy, cardiomyopathy and Dunnigan-type partial lipodystrophy. J. Cell Sci. 114 (2001) 4435-4445
32. Furukawa K. LAP2 binding protein 1 (L2BP1/BAF) is a candidate mediator of LAP2-chromatin interaction. J. Cell Sci. 112 Pt. 15 (1999) 2485-2492
33. Morris G.E. Nuclear proteins and cell death in inherited neuromuscular disease. Neuromuscul. Disord. 10 (2000) 217-227
34. Wilson K.L., Zastrow M.S., and Lee K.K. Lamins and disease: insights into nuclear infrastructure. Cell 104 (2001) 647-650